ENTITY
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (TIAN SP)

1
Analysis
Health Care • China
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments. The Group also manufactures gene-related biopharmaceutical products. Tianjin Zhongxin markets its products under the Great Wall, Cypress, and Health brand names.
more
•26 Jun 2025 17:00•Syndicated

1H 2025 Dividend Investing Update: Navigating the Yield Squeeze

Singapore's equity market is positioned to continue its resilient performance, with benchmark indices trending positively and dividend yields...

Logo
Syfe
15 Views
Share
bullish•Starhill Global REIT
•22 Mar 2021 00:00•Exchange-sponsored

Singapore Mid-Caps Edge Ahead of Regional Peers in YTD

Singapore’s current crop of 63 Mid-Cap stocks, with a market value between S$1 billion and S$5 billion, have averaged a 12% total return (6%...

Share
bullish•Gsh Corp Ltd
•21 Jan 2021 00:00•Exchange-sponsored

Growth Stocks Edge Higher with Value Stocks in Early 2021

Singapore stocks that recently ranked highly for Growth Factor Exposure have kept pace, and been marginally stronger than Value stock...

Share
bullish•UOB
•29 Dec 2020 00:00•Exchange-sponsored

Recent Market Rebound Extended to Value Stocks

Four of the STI’s 10 strongest performers in the 4Q-to-date ranked highly for the Value factors in early 2H20. These four stocks were Jardine...

Share
x